As of 2026-09-17, the Fair Value of Seres Therapeutics Inc (MCRB) is -58.01 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.21 USD, the upside of Seres Therapeutics Inc is -1,478.00%.
With the market price of 4.21 USD and our fair value calculation, Seres Therapeutics Inc (MCRB) is not a good investment. Investing in MCRB stocks now will result in a potential loss of 1,478.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -65.58 | -250.16 | -113.72 | 0.14 | 5.70 | -84.73 |
| YoY growth | 26.42% | -281.46% | 54.54% | 100.12% | 4,088.24% | 797.57% |
| Market Cap (mil) | 40.75 |
| P/E | |
| Forward P/E | 0.63x |
| EPS | -2.32 |
| Avg earnings growth rate | 797.57% |
| TTM earnings | -22.46 |